Sentinel Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
HM
Sentinel Asset Management's HAE Position: Q4 2017 in Review
Sentinel Asset Management sold out of Haemonetics (HAE) in Q4 2017, closing a stake of 350,226 shares — an estimated $15.7M sold.
Sentinel Asset Management first reported a position in HAE in Q2 2013 and held it in 18 quarters. The position peaked at $18M in Q1 2015. 246 funds tracked by Wall St. Rank hold HAE as of Q4 2017.
- Sentinel Asset Management reported no remaining Haemonetics position as of Q4 2017 after selling out during the quarter.
- Sentinel Asset Management sold 350,226 Haemonetics shares in Q4 2017, an estimated $15.7M.
- Sentinel Asset Management first reported a position in Haemonetics in Q2 2013 and held it in 18 quarters.
- Sentinel Asset Management's Haemonetics position peaked at $18M in Q1 2015.
- 246 funds tracked by Wall St. Rank held Haemonetics as of Q4 2017.
Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.